Derma Sciences Cmn (DSCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2000 | 12-1999 | 12-1998 | 12-1993 | 12-1992 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,581 | -2,400 | -1,810 | 245 | -50 |
| Depreciation Amortization | 357 | 230 | 300 | 43 | 37 |
| Accounts receivable | 45 | 0 | 0 | 0 | 0 |
| Accounts payable and accrued liabilities | -240 | 0 | 0 | 0 | 0 |
| Other Working Capital | -140 | -660 | -220 | -200 | -205 |
| Other Operating Activity | 1,987 | 120 | -460 | 0 | 0 |
| Operating Cash Flow | $-573 | $-2,710 | $-2,190 | $88 | $-218 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -23 | -80 | -120 | -16 | -29 |
| Net Acquisitions | N/A | 0 | -1,520 | 0 | 0 |
| Other Investing Activity | 0 | 0 | -10 | -17 | -13 |
| Investing Cash Flow | $-23 | $-80 | $-1,650 | $-33 | $-41 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -10 | 0 | 0 | 0 | 0 |
| Debt Issued | 150 | 0 | 0 | 0 | 0 |
| Common Stock Issued | 308 | 0 | 0 | 0 | 0 |
| Other Financing Activity | 0 | 1,680 | 3,670 | 11 | 220 |
| Financing Cash Flow | $448 | $1,680 | $3,670 | $11 | $220 |
| Beginning Cash Position | 572 | 2,330 | 2,510 | 44 | 83 |
| End Cash Position | 424 | 1,220 | 2,330 | 110 | 44 |
| Net Cash Flow | $-148 | $-1,110 | $-170 | $66 | $-39 |
| Free Cash Flow | |||||
| Operating Cash Flow | -573 | -2,710 | -2,190 | 88 | -218 |
| Capital Expenditure | -23 | 0 | 0 | 0 | 0 |
| Free Cash Flow | -595 | -2,710 | -2,190 | 88 | -218 |